References

Atanasov G, Benckert C, Thelen A Alveolar echinococcosis — spreading disease challenging clinicians: a case report and literature review. World J Gastroenterol. 2013; 19:(26)4257-61

Dyachenko V, Pantchev N, Gawlowska S, Vrhovec M, Bauer C Echinococcus multilocularis infection in domestic dogs and cats from Germany and other European countries. Vet Parasitol. 2008; 157:(3–4)244-53

ESCCAP. Worm control in dogs and cats Guideline 1, 2nd edition [pdf] ESCCAP. 2010. http://www.esccap.org/uploads/docs/nkzqxmxn_esccapgl1endoguidelines.pdf (accessed 11th April, 2014)

Hegglin D, Bontadina F, Gloor S, Romig T, Deplazes P, Kern P Survey of public knowledge about Echinococcus multilocularis in four European countries: need for proactive information. BMC Public Health. 2008; 8

Hegglin D, Deplazes P Control of Echinococcus multilocularis: strategies, feasibility and cost-benefit analyses. Int J Parasitol. 2013; 43:(5)327-37

Ito A, Romig T, Takahashi K Perspective on control options for Echinococcus multilocularis with particular reference to Japan. Parasitology. 2003; 127:(1)S159-S172

Kern P, Ammon A, Kron M Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis. 2004; 10:(12)2088-93

Kreidl P, Allerberger F, Judmaier G, Auer H, Aspock H, Hall A Domestic pets as risk factors for alveolar hydatid disease in Austria. Am J Epidemiol. 1998; 147:(10)978-81

Pawlowski Z, Eckert J, Vuitton D Echinococcosis in humans: clinical aspects, diagnosis and treatment. WHO/OIE Manual on Echinococcosis in Humans and Animals: a Public Health Problem of Global Concern Paris: World Heath Organisation. 2002; 2:20-71

Piarroux M, Piarroux R, Knapp J Populations at Risk for Alveolar Echinococcus, France. Emerging Infectious Diseases. 2013; 19:(5)721-8

Sanco. Comments of the European Union on annexes XXXI and XXXIII of the report of the February 2012 meeting of the Terrestrial Animal Health Standards Commission to the OIE [pdf] European Union. 2012. http://ec.europa.eu/food/international/organisations/docs/eu_comments_tahsc_report_feb2012_en.pdf (accessed 11th April, 2014)

Thompson R, Kapel C, Hobbs R, Deplazes P Comparative development of Echinococcus multilocularis in its definitive hosts. Parasitology. 2006; 132:(5)709-16

Torgerson P, Schweiger A, Deplazes P Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol. 2008; 49:(1)72-7

van Knapen F Discussion about echinococcosis in the Netherlands. 2014;

Update on Echinococcus multilocularis with particular emphasis on its impact on humans

02 May 2014
7 mins read
Volume 5 · Issue 4

Abstract

The range of Echinococcus multilocularis has extended over the past 4 years, effectively removing the ‘buffer zone’ of land between the channel coast and the western-most edge of its endemic area. This means that pet owners taking their dogs and cats across the channel should consider treating their dogs or cats at monthly intervals with a suitable cestocide containing praziquantel or equivalent if there is any chance of the pet having access to rodents. The role of cats as significant producers of eggs is markedly less than that of foxes or dogs. However the role of the cat as a source of infection within the domestic environment is less well defined.

Infection of humans has a lag time of between 5 and 15 years before clinical signs are seen, thus it will be some time before the scale of zoonotic infections is known from the areas where the infection has now spread to. Diagnosis in humans relies on serology, polymerase chain reaction (PCR), and magnetic resonance imaging (MRI) or computed tomography (CT) scans to detect characteristic cystic lesions normally in the liver. Cure is most likely to be achieved if resection of the entire lesion is possible. Long-term benzimidazole treatment is normally administered to ensure control.

In addition to regular cestocidal treatment of dogs and cats, cleanliness measures including hand washing before eating and wearing gloves when gardening can help with preventing human infection.

The focus in the UK on the parasite E. multilocularis has largely been associated with maintaining the requirement for pre-entry treatment of dogs, which of course was successfully maintained with the rule changes introduced in January 2012. While that was a milestone it was by no means the end of the story. The range of the parasite continues to increase dramatically in Europe, there is some increase in understanding of the risk factors associated with human infection and it is acknowledged that this infection has a zoonotic impact even in developed, wealthy European countries. Current EU focus appears to be on ensuring that those countries currently fortunate enough not to have the infection present in their country have a sufficiently rigorous scientific process to prove that the country remains free of infection: there appears to be no initiatives to control the infection in countries where it is endemic. Owners with dogs and cats travelling to the areas where this infection is now endemic should be aware of the risk and take suitable measures to prevent zoonotic infection and to control infection in their pets. This review does not go systematically through all aspects of the infection and these details can be found on, for example, the www.esccapuk.org.uk website.

Register now to continue reading

Thank you for visiting The Veterinary Nurse and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.